Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation.

We found no significant difference between standard and expanded SNP assays in detecting AR. We show improved specificity without change in sensitivity using dd-cfDNA in place of GEP testing. Prospective controlled studies to address how to best implement dd-cfDNA testing into clinical practice are needed.